+Susen Rogen

Thursday, 3 October 2013

Malaysia Pharmaceuticals and Healthcare Report Q4 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports
 
Exotic travel ideas.

Searching for your next vacation destination? Subscribe to Off The Beaten Path, a newsletter featuring captivating locales to help you to plan your next trip.
From our sponsors
Malaysia Pharmaceuticals and Healthcare Report Q4 2013
Oct 2nd 2013, 00:00, by swapnil

BMI View: Malaysia’s pharmaceuticals and healthcare market continues to grow, and government support to both the industry and the roll out of universal healthcare means that its growth prospects are good throughout the course of our 10 year forecast period. While communicable diseases have historically defined the burden of disease, lifestyle changes and an expanding middle class mean that noncommunicable diseases are now gaining prominence. The country is also gaining an important reputation as a hub for medical tourism, although problems, in terms of shortages of healthcare personnel, remain. Headline Expenditure Projections ? Pharmaceuticals: MYR6.06bn (US$1.96bn) in 2012 to MYR6.5bn …

Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=118171.

Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/malaysia-pharmaceuticals-and-healthcare-report-q4-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

No comments:

Post a Comment